ABOS Acumen Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 12, 2026
$2,04
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,5052 haftanın en düşüğü
$3,6052 haftanın en yükseği
Piyasa Değeri (MRQ)
$148M
P/E
-1.2
Hisse Başına Kâr
$-2.00
rozetleriniz
52 Haftlık Aralık
$2–$4
Analist Derecelendirmesi
STRONG BUY
Fiyat Hedefi
$8
P/E
-1.2
ROE
-129.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ABOS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$2.04
Piyasa Değeri (MRQ)
$148M
P/E
-1.2
Hisse Başına Kâr
$-2.00
ROE
-129.4%
D/E Borç/Özsermaye (MRQ)
0.3
52 Haftlık Aralık
$2–$4
ABOS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-2.002021-12-31 → 2025-12-31
Serbest Nakit Akışı$-116M2021-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ABOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -1.25Y ort. ≈-2.4 | ≈-2.4 | · | · | |
| F/D (MRQ) | 2.65Y ort. ≈1.1 | ≈1.1 | 2.5 | Aşırı değerli | |
| EV / EBITDA | -0.3 | · | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.65Y ort. ≈-5.8 | ≈-5.8 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.65Y ort. ≈-5.8 | ≈-5.8 | · | · | |
| EV / FCF (TTM) | -0.6 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 2.15Y ort. ≈1.1 | ≈1.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ABOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -67.1%5Y ort. ≈-43.7% | ≈-43.7% | -56.4% | Zayıf | |
| ROE | -129.4%5Y ort. ≈-53.2% | ≈-53.2% | -60.0% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ABOS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.3 | · | 0.1 | Yüksek borç | |
| Cari Oran (MRQ) | 2.55Y ort. ≈13.2 | ≈13.2 | 9.2 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 3.95Y ort. ≈8.7 | ≈8.7 | 7.8 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
2.6%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.45 | $-0.37 | -20.2% |
| 31 Mart 2026 | May 19, 2026 | $-0.33 | $-0.41 | 19.7% |
| 31 Aralık 2025 | $-0.41 | $-0.46 | 11.3% | |
| 30 Eylül 2025 | $-0.44 | $-0.62 | 28.5% | |
| 30 Haziran 2025 | $-0.68 | $-0.55 | -23.9% | |
| 31 Mart 2025 | $-0.48 | $-0.68 | 29.1% | |
| 31 Aralık 2024 | $-0.62 | $-0.49 | -26.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $105M | $94M | $42M | $32M | $12M | $8M | |
| SG&A Expense | $19M | $20M | $19M | $13M | $7M | $1M | |
| Operating Expenses | $124M | $114M | $61M | $45M | $20M | $9M | |
| Operating Income | $-124M | $-114M | $-61M | $-45M | $-20M | $-8M | |
| Interest Expense | · | · | $581.0K | $0 | · | · | |
| Interest Income | $7M | $14M | $11M | $2M | · | · | |
| Other Non-op | $-266.0K | $-151.0K | $-83.0K | $-11.0K | $51.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-121M | $-102M | $-52M | $-43M | $-101M | $-7M | |
| EPS (Basic) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| EPS (Diluted) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · | |
| Shares (Basic) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| Shares (Diluted) | 60,561,836 | 60,013,277 | 48,609,383 | 40,601,936 | 20,057,534 | · | |
| EBITDA | $-124M | $-114M | $-61M | $-45M | $-20M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $36M | $67M | $130M | $122M | $44M | |
| Short-term Investments | $63M | $136M | $177M | $48M | $72M | · | |
| Prepaid Expense | $5M | $7M | $3M | $3M | $4M | $543.0K | |
| Other Current Assets | · | · | $283.0K | $237.0K | $140.0K | · | |
| Current Assets | $122M | $178M | $247M | $180M | $199M | $44M | |
| PP&E (Net) | $103.0K | $73.0K | $122.0K | $165.0K | $36.0K | · | |
| Accum. Depreciation | $200.0K | $100.0K | $100.0K | · | · | · | |
| Other Non-current Assets | $350.0K | $486.0K | $724.0K | $151.0K | $14.0K | $0 | |
| Total Assets | $123M | $239M | $310M | $197M | $230M | $44M | |
| Accounts Payable | $554.0K | $6M | $1M | $2M | $1M | $531.0K | |
| Accrued Liabilities | $10M | $7M | $6M | $3M | · | · | |
| Short-term Debt | $9M | $0 | · | · | · | · | |
| Current Liabilities | $30M | $28M | $13M | $8M | $5M | · | |
| Capital Leases | · | $150.0K | $284.0K | $0 | · | · | |
| Other Non-current Liabilities | $0 | $150.0K | $284.0K | · | · | · | |
| Total Liabilities | $52M | $57M | $43M | $8M | $5M | $6M | |
| Long-term Debt | $22M | $29M | $30M | $0 | · | · | |
| Total Debt | $9M | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $517M | $507M | $489M | $360M | $353M | $8M | |
| Retained Earnings | $-446M | $-325M | $-223M | $-170M | $-128M | $-27M | |
| AOCI | $83.0K | $-48.0K | $312.0K | $-751.0K | · | · | |
| Stockholders' Equity | $70M | $182M | $267M | $189M | $225M | $-19M | |
| Liabilities + Equity | $123M | $239M | $310M | $197M | $230M | $44M | |
| Shares Outstanding | 60,575,369 | 60,094,083 | 57,910,461 | 41,025,062 | 40,473,270 | 419,124 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $6M | $3M | $922.0K | $154.0K | |
| Operating Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | $-7M | |
| CapEx | $88.0K | $16.0K | $21.0K | $161.0K | $40.0K | · | |
| Investing Cash Flow | $134M | $48M | $-172M | $39M | $-104M | · | |
| Stock Issued | $0 | $8M | $122M | $4M | $169M | · | |
| Net Stock Activity | $0 | $8M | $122M | $4M | $169M | · | |
| Financing Cash Flow | $-34.0K | $7M | $152M | $4M | $200M | $45M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-116M | $-86M | $-43M | $-35M | $-18M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.1% | -37.3% | -20.7% | -20.1% | -73.2% | · | |
| ROE | -129.4% | -51.3% | -19.1% | -22.2% | -43.9% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 6.5 | 19.0 | 23.1 | · | · | |
| Quick Ratio | 3.9 | 6.2 | 18.8 | 6.1 | · | · | |
| Debt / Equity | 0.1 | · | · | · | · | · | |
| Interest Coverage | · | · | -105.2 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $3.03 | $4.61 | $4.60 | $5.56 | · | |
| Cash Flow / Share | $-1.91 | $-1.44 | $-0.89 | $-0.87 | · | · | |
| Cash / Share | $0.89 | $0.59 | $1.16 | · | $3.02 | · | |
| EPS (TTM) | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-121M | $-102M | $-52M | $-43M | $-101M | · | |
| Market Cap | $128M | $103M | $222M | $222M | $274M | · | |
| Enterprise Value | $20M | · | · | · | · | · | |
| P/E | -1.1 | -1.0 | -3.6 | -5.1 | -1.3 | · | |
| P/B | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | 1.8 | 0.6 | 0.8 | 1.2 | 1.2 | · | |
| P / Cash Flow | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| P / FCF | -1.1 | -1.2 | -5.2 | -6.3 | -15.2 | · | |
| EV / EBITDA | -0.2 | · | · | · | · | · | |
| EV / FCF | -0.2 | · | · | · | · | · | |
| Earnings Yield | -94.8% | -99.4% | -28.1% | -19.6% | -74.3% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $16M | $21M | $22M | $37M | $25M | $35M | $27M | $20M | $12M | $13M | $11M | $9M | $9M | $11M | $8M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $33M | $21M | $25M | $27M | $42M | $30M | $40M | $32M | $24M | $18M | $18M | $16M | $13M | $13M | $14M | $11M | |
| Operating Income | $-33M | $-21M | $-25M | $-27M | $-42M | $-30M | $-40M | $-32M | $-24M | $-18M | $-18M | $-16M | $-13M | $-13M | $-14M | $-11M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | · | · | $0 | · | · | |
| Interest Income | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | · | · | |
| Other Non-op | $-19.0K | $-43.0K | $-4.0K | $-69.0K | $-129.0K | $-64.0K | $-62.0K | $33.0K | $-68.0K | $-54.0K | $-21.0K | $-42.0K | $-16.0K | $-4.0K | $-10.0K | $-2.0K | |
| Net Income | $-33M | $-21M | $-25M | $-26M | $-41M | $-29M | $-37M | $-30M | $-21M | $-15M | $-16M | $-13M | $-12M | $-11M | $-13M | $-11M | |
| EPS (Basic) | $-0.45 | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | |
| EPS (Diluted) | $-0.45 | $-0.33 | $-0.40 | $-0.44 | $-0.68 | $-0.48 | $-0.62 | $-0.50 | $-0.34 | $-0.25 | $-0.28 | $-0.24 | $-0.28 | $-0.28 | $-0.32 | $-0.26 | |
| Shares (Basic) | 72,250,694 | 63,219,289 | · | 60,573,425 | 60,573,425 | 60,525,628 | · | 60,079,778 | 60,079,778 | 59,812,000 | · | 54,229,630 | 41,025,062 | 41,025,062 | · | 40,502,860 | |
| Shares (Diluted) | 72,250,694 | 63,219,289 | · | 60,573,425 | 60,573,425 | 60,525,628 | · | 60,079,778 | 60,079,778 | 59,812,000 | · | 54,229,630 | 41,025,062 | 41,025,062 | · | 40,502,860 | |
| EBITDA | $-33M | $-21M | · | $-27M | $-42M | $-30M | · | $-32M | $-24M | $-18M | · | $-16M | $-13M | $-13M | · | $-11M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $59M | $52M | $54M | $47M | $37M | $30M | $36M | $33M | $68M | $47M | $67M | $95M | · | · | $130M | $158M | |
| Short-term Investments | $51M | $77M | $63M | $80M | $107M | $119M | $136M | $167M | $193M | $206M | $177M | $121M | $68M | $62M | $48M | $43M | |
| Prepaid Expense | $5M | $5M | $5M | $6M | $5M | $6M | $7M | $7M | $6M | $3M | $3M | $3M | $5M | $4M | $3M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | $457.0K | $405.0K | $395.0K | · | $181.0K | $208.0K | $294.0K | $237.0K | · | |
| Current Assets | $116M | $133M | $122M | $132M | $148M | $155M | $178M | $208M | $267M | $256M | $247M | $219M | $150M | $144M | $180M | $203M | |
| PP&E (Net) | $80.0K | $91.0K | $103.0K | $115.0K | $130.0K | $137.0K | $73.0K | $89.0K | $105.0K | $117.0K | $122.0K | $123.0K | $136.0K | $151.0K | · | $142.0K | |
| Accum. Depreciation | $100.0K | $200.0K | $200.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | · | · | $100.0K | · | · | · | · | · | |
| Other Non-current Assets | $263.0K | $304.0K | $350.0K | $393.0K | $464.0K | $504.0K | $486.0K | $170.0K | $425.0K | $324.0K | $724.0K | $189.0K | $208.0K | $195.0K | $151.0K | $92.0K | |
| Total Assets | $116M | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | |
| Accounts Payable | $13M | $2M | $554.0K | $682.0K | $2M | $1M | $6M | $2M | $4M | $3M | $1M | $1M | $2M | $762.0K | $2M | $2M | |
| Accrued Liabilities | $8M | $5M | $10M | $8M | $12M | $7M | $7M | $5M | $4M | $3M | $6M | $3M | $2M | · | $3M | · | |
| Short-term Debt | $20M | $14M | $9M | $4M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $47M | $29M | $30M | $22M | $25M | $19M | $28M | $20M | $15M | $8M | $13M | $6M | $9M | $9M | $8M | $7M | |
| Capital Leases | · | · | · | $39.0K | $77.0K | $114.0K | $150.0K | $185.0K | $219.0K | $252.0K | $284.0K | · | · | · | $0 | · | |
| Other Non-current Liabilities | · | · | $0 | $39.0K | $77.0K | $114.0K | $150.0K | · | · | · | $284.0K | · | · | · | · | · | |
| Total Liabilities | $59M | $46M | $52M | $49M | $55M | $49M | $57M | $50M | $45M | $39M | $43M | $6M | $9M | $9M | $8M | $7M | |
| Long-term Debt | $12M | $17M | $22M | $27M | $30M | $30M | $29M | $30M | $29M | $30M | $30M | · | · | · | $0 | · | |
| Total Debt | $20M | $14M | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $557M | $555M | $517M | $514M | $512M | $509M | $507M | $505M | $502M | $500M | $489M | $487M | $363M | $361M | $360M | $355M | |
| Retained Earnings | $-500M | $-467M | $-446M | $-421M | $-395M | $-354M | $-325M | $-288M | $-258M | $-238M | $-223M | $-206M | $-193M | $-182M | $-170M | $-158M | |
| AOCI | $-13.0K | $21.0K | $83.0K | $109.0K | $23.0K | $15.0K | $-48.0K | $518.0K | $-164.0K | $-144.0K | $312.0K | $-509.0K | $-646.0K | · | $-751.0K | · | |
| Stockholders' Equity | $57M | $87M | $70M | $93M | $117M | $156M | $182M | $217M | $244M | $262M | $267M | $280M | $169M | $179M | $189M | $197M | |
| Liabilities + Equity | $116M | $134M | $123M | $142M | $172M | $204M | $239M | $267M | $289M | $301M | $310M | $286M | $177M | $188M | $197M | $203M | |
| Shares Outstanding | 72,314,714 | 72,227,580 | 60,575,369 | 60,573,425 | 60,573,425 | 60,573,425 | 60,094,083 | 60,079,778 | 60,079,778 | 60,079,778 | 57,910,461 | 57,910,461 | 41,025,062 | 41,025,062 | 41,025,062 | 40,503,124 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $888.0K | $840.0K | |
| Operating Cash Flow | $-18M | $-24M | $-19M | $-30M | $-32M | $-34M | $-27M | $-25M | $-17M | $-18M | $-8M | $-13M | $-12M | $-10M | $-11M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $9.0K | $79.0K | $0 | $0 | $5.0K | $11.0K | $14.0K | $7.0K | $0 | $0 | $35.0K | $81.0K | |
| Investing Cash Flow | $26M | $-14M | $26M | $41M | $38M | $29M | $30M | $-10M | $38M | $-9M | $-49M | $-92M | $11M | $-42M | $-20M | $56M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8M | $-390.0K | $122M | $0 | $0 | $4M | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $8M | · | · | · | · | · | · | |
| Financing Cash Flow | $-278.0K | $36M | $2.0K | $0 | $0 | $-36.0K | $-9.0K | $-42.0K | $-128.0K | $7M | $29M | $123M | $-145.0K | $0 | $4M | $-263.0K | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Free Cash Flow | · | $-24M | · | · | · | $-34M | · | · | · | $-18M | · | · | · | $-10M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -22.7% | -12.3% | · | -12.9% | -17.8% | -11.4% | · | -10.8% | -8.8% | -6.1% | · | -5.3% | -6.0% | -5.5% | · | -4.9% | |
| ROE | -37.5% | -17.1% | · | -17.0% | -22.7% | -13.8% | · | -12.0% | -10.0% | -6.7% | · | -5.4% | -6.2% | -5.7% | · | -5.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 4.6 | · | 6.0 | 6.0 | 8.0 | · | 10.4 | 17.4 | 30.2 | · | 35.8 | 17.5 | 16.4 | · | 30.6 | |
| Quick Ratio | 2.4 | 4.4 | · | 5.8 | 5.8 | 7.7 | · | 10.1 | 17.0 | 29.8 | · | 35.3 | 7.9 | 7.1 | · | 30.3 | |
| Debt / Equity | 0.3 | 0.2 | · | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.8 | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.79 | $1.21 | · | $1.54 | $1.93 | $2.57 | · | $3.62 | $4.06 | $4.36 | · | $4.84 | $4.12 | $4.37 | · | $4.86 | |
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.56 | · | · | · | $-0.30 | · | · | · | $-0.25 | · | · | |
| Cash / Share | $0.82 | $0.72 | · | $0.77 | $0.61 | $0.50 | · | $0.55 | $1.13 | $0.78 | · | $1.64 | · | · | · | $3.89 | |
| EPS (TTM) | $-1.62 | $-1.85 | · | $-2.22 | $-2.28 | $-1.94 | · | $-1.37 | $-1.11 | $-1.05 | · | $-1.12 | $-1.14 | $-1.11 | · | $1.24 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-105M | $-113M | · | $-133M | $-137M | $-116M | · | $-82M | $-65M | $-56M | · | $-49M | $-46M | $-45M | · | $-38M | |
| Market Cap | $193M | $170M | · | $104M | $70M | $67M | · | $149M | $145M | $243M | · | $240M | $197M | $167M | · | $406M | |
| Enterprise Value | $103M | $56M | · | $-19M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.6 | -1.3 | · | -0.8 | -0.5 | -0.6 | · | -1.8 | -2.2 | -3.9 | · | -3.7 | -4.2 | -3.7 | · | 8.1 | |
| P/B | 3.4 | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | |
| P / Tangible Book | 3.4 | 1.9 | · | 1.1 | 0.6 | 0.4 | · | 0.7 | 0.6 | 0.9 | · | 0.9 | 1.2 | 0.9 | · | 2.1 | |
| P / Cash Flow | · | -7.1 | · | · | · | -2.0 | · | · | · | -13.6 | · | · | · | -16.4 | · | · | |
| Earnings Yield | -60.7% | -78.4% | · | -129.8% | -196.6% | -176.4% | · | -55.2% | -45.9% | -25.9% | · | -27.0% | -23.7% | -27.3% | · | 12.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-121M | $-102M | $-52M | $-43M | $-101M |
| Seyreltilmiş Hisse Başı Kâr | $-2.00 | $-1.71 | $-1.08 | $-1.06 | $-5.02 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.1 | · | · | · | · |
| Cari Oran | 4.1 | 6.5 | 19.0 | 23.1 | · |
| Cari Oran | 3.9 | 6.2 | 18.8 | 6.1 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-116M | $-86M | $-43M | $-35M | $-18M |
Kurumsal Sahipler (13F) 102 dosya · $131.5M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
102
Tutulan Değer
$131.5M
Yeni pozisyonlar
30
Çıkan pozisyonlar
17
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 30 (+4 önceki Ç'ye göre) | 17 (+12 önceki Ç'ye göre) | 22 (-9 önceki Ç'ye göre) | 15 (+3 önceki Ç'ye göre) | +1.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $56.050.426 | 20.992.669 | 42,62% | Hisse senetleri |
| Sands Capital Alternatives, LLC | $9.932.680 | 3.720.105 | 7,55% | Hisse senetleri |
| BlackRock, Inc. | $6.648.607 | 2.490.115 | 5,05% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $6.554.193 | 2.454.754 | 4,98% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $6.154.606 | 2.305.096 | 4,68% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $5.637.262 | 2.111.334 | 4,29% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.464.432 | 1.672.072 | 3,39% | Hisse senetleri |
| Knollwood Investment Advisory, LLC | $4.348.122 | 1.628.510 | 3,31% | Hisse senetleri |
| VANGUARD GROUP INC | $3.489.459 | 1.653.772 | 2,65% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.049.286 | 1.141.858 | 2,32% | Hisse senetleri |
| Ikarian Capital, LLC | $2.813.638 | 1.053.797 | 2,14% | Hisse senetleri |
| Hudson Bay Capital Management LP | $2.549.850 | 955.000 | 1,94% | Hisse senetleri |
| Pathstone Holdings, LLC | $2.293.824 | 859.110 | 1,74% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.802.317 | 675.025 | 1,37% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.663.095 | 622.882 | 1,26% | Hisse senetleri |
| STATE STREET CORP | $1.603.410 | 600.528 | 1,22% | Hisse senetleri |
| NORTHERN TRUST CORP | $963.187 | 360.744 | 0,73% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $889.998 | 421.800 | 0,68% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $856.523 | 320.795 | 0,65% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $778.969 | 291.559 | 0,59% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $777.611 | 291.240 | 0,59% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $733.665 | 274.781 | 0,56% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $728.942 | 273.012 | 0,55% | Hisse senetleri |
| NOMURA HOLDINGS INC | $506.531 | 189.712 | 0,39% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $491.085 | 183.927 | 0,37% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $470.377 | 176.171 | 0,36% | Hisse senetleri |
| MORGAN STANLEY | $365.157 | 136.763 | 0,28% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $336.698 | 126.104 | 0,26% | Hisse senetleri |
| Bank of New York Mellon Corp | $332.086 | 124.377 | 0,25% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $307.314 | 115.099 | 0,23% | Hisse senetleri |
| PFG Investments, LLC | $251.648 | 94.250 | 0,19% | Hisse senetleri |
| CATALYST FINANCIAL PARTNERS LLC | $239.496 | 89.699 | 0,18% | Hisse senetleri |
| Nuveen, LLC | $169.158 | 63.355 | 0,13% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $161.797 | 60.598 | 0,12% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $158.598 | 59.400 | 0,12% | Alım opsiyonu |
| Squarepoint Ops LLC | $139.777 | 52.351 | 0,11% | Hisse senetleri |
| CITADEL ADVISORS LLC | $136.301 | 51.049 | 0,10% | Hisse senetleri |
| Prospera Financial Services Inc | $133.500 | 50.000 | 0,10% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $132.661 | 49.686 | 0,10% | Hisse senetleri |
| MARSHALL WACE, LLP | $128.465 | 48.114 | 0,10% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $123.172 | 46.132 | 0,09% | Hisse senetleri |
| Verdad Advisers, LP | $118.756 | 44.478 | 0,09% | Hisse senetleri |
| BARCLAYS PLC | $105.878 | 39.655 | 0,08% | Hisse senetleri |
| Qube Research & Technologies Ltd | $103.099 | 38.614 | 0,08% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $96.654 | 36.200 | 0,07% | Hisse senetleri |
| RHUMBLINE ADVISERS | $93.535 | 35.034 | 0,07% | Hisse senetleri |
| Rangeley Capital, LLC | $93.450 | 35.000 | 0,07% | Hisse senetleri |
| XTX Topco Ltd | $85.798 | 32.134 | 0,07% | Hisse senetleri |
| Intrepid Financial Planning Group LLC | $80.501 | 30.150 | 0,06% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $78.872 | 29.540 | 0,06% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 başvurular | 17 Mart 2026 | 29,50% | Değişiklik | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 17 içeriden öğrenenler · 7 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Daniel Joseph Oconnell | Chief Executive Officer | 22 Ocak 2026 S | 881.275 | 0 | 8 | $-163.230 |
| Matt Zuga | CFO & Chief Business Officer | 22 Ocak 2026 S | 304.924 | 0 | 7 | $-49.630 |
| James J. Doherty | President and CDO | 16 Ocak 2026 A | 220.900 | 0 | 2 | $-15.153 |
| Russell Barton | Chief Operating Officer | 22 Ocak 2026 S | 205.092 | 0 | 6 | $-29.956 |
| Derek M Meisner | Chief Legal Officer & Corp Sec | 06 Mart 2026 M | 173.999 | 0 | 16 | $-248.780 |
| Eric Siemers | Chief Medical Officer | 22 Ocak 2026 S | 255.371 | 0 | 4 | $-27.128 |
| Amy Schacterle | Chief Regulatory Officer | 16 Ocak 2026 A | 92.303 | 0 | 1 | $-2.172 |
| Derrell Porter | Yönetim kurulu üyesi | 17 Haziran 2026 M | 35.500 | 0 | 3 | $-75.388 |
| Nathan B Fountain | Yönetim kurulu üyesi | 09 Haziran 2026 S | 48.150 | 0 | 1 | $-14.272 |
| Laura Stoppel | Yönetim kurulu üyesi | 03 Haziran 2026 A | 48.300 | 0 | 0 | $0 |
| John A Stalfort III | Yönetim kurulu üyesi | 03 Haziran 2026 A | 220.624 | 0 | 0 | $0 |
| Jeffrey L. Ives | Yönetim kurulu üyesi | 03 Haziran 2026 A | 48.300 | 0 | 0 | $0 |
| George Golumbeski | Yönetim kurulu üyesi | 03 Haziran 2026 A | 35.500 | 0 | 0 | $0 |
| Kimberlee C Drapkin | Yönetim kurulu üyesi | 03 Haziran 2026 A | 48.300 | 0 | 0 | $0 |
| Jeffrey Sevigny | Yönetim kurulu üyesi | 15 Haziran 2022 A | · | 0 | 0 | $0 |
| Robert D. Hardie | 10% sahip | 06 Temmuz 2021 C | 657.985 | 0 | 0 | $0 |
| Paul B Manning | 10% sahip | 06 Temmuz 2021 C | 657.985 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 14 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,19% | 5.024 SH | 11 Eylül 2026 | Günlük |
| IWC · iShares Trust | 0,03% | 157.585 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 41.102 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,00% | 1.017.131 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,00% | 22.560 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4.079 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 100.013 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 7.149 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 513.511 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.118.322 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 273.215 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.478 SH | 19 Ağustos 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 9.637 NS | 31 Temmuz 2026 | N-PORT |
| IWN · iShares Trust | · | 427.467 SH | 11 Eylül 2026 | Günlük |
ABOS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 12 analist
AL
Medyan hedef
$8.00
+292,2%
6 50,0%
Güçlü Al
5 41,7%
Al
1 8,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-10-02Ortalama hedef $7.60 +272,5%
← Tüm hedeflerin altında
Mevcut fiyat $2.04
Düşük$5.00
Ortalama$7.60
Yüksek$10.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | · |
| HUMA | · | · | · | · | · | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 12, 2026